TRAF3IP3 and central nervous system cancer: On the other hand, TRAF3IP3 may facilitate glioma development by activating the ERK signaling pathway (Lin et al., 2022; Yang et al., 2021), while acting as a protective gene in patients with lung adenocarcinoma (Liu et al., 2021).